Ellagic acid references

1.) Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals.
Nepka C, Asprodini E, Kouretas D. Eur J Drug Metab Pharmacokinet; 24(2):183-9 1999 UI: 99440448

2.) The effects of ellagic acid on arylamine N-acetyltransferase activity in the bacterium Pseudomonas
aeruginosa. Lo HH, Hsieh SE, Tsai KJ, Chung JG. Drug Chem Toxicol; 22(3):555-62 1999 UI: 99374190

3.) Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin
in mice. Khanduja KL, Gandhi RK, Pathania V, Syal N. Food Chem Toxicol; 37(4):313-8 1999 UI: 99345316

4.) p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid
treated cancer cells. Narayanan BA, Geoffroy O, Willingham MC, Re GG, Nixon DW. Cancer Lett;
136(2):215-21 1999 UI: 99281882

5.) Determining efficacy of cancer chemopreventive agents using a cell-free system concomitant with
DNA adduction. Smith WA, Gupta RC. Mutat Res; 425(1):143-52 1999 UI: 99185178

6.) Isothiocyanates and freeze-dried strawberries as inhibitors of esophageal cancer. Stoner GD,
Kresty LA, Carlton PS, Siglin JC, Morse MA. Toxicol Sci; 52(2 Suppl):95-100 1999 UI: 20094292

7.) Protective effect of curcumin, ellagic acid and bixin on radiation induced genotoxicity.
Thresiamma KC, George J, Kuttan R. J Exp Clin Cancer Res; 17(4):431-4 1998 UI: 99186924

8.) Polyphenols inhibit promotional phase of tumorigenesis: relevance of superoxide radicals.
Kaul A, Khanduja KL. Nutr Cancer; 32(2):81-5 1998 UI: 99118269

9.) Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta
1-1 levels. Ivan Lieshout EM, Bedaf MM, Pieter M, Ekkel C, Nijhoff WA, Peters WH. Carcinogenesis;
19(11):2055-7 1998 UI: 99070666

10.) Biodistribution of, antimutagenic efficacies in Salmonella typhimurium of, and inhibition of P450 activities by ellagic acid and one analogue. Castonguay A, Boukharta M, Teel R. Chem Res Toxicol; 11(11):1258-64 1998 UI: 99034533

11.) In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Soliman KF, Mazzio EA. Proc Soc Exp Biol Med; 218(4):390-7 1998 UI: 98377887

12.) [Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey] Radtke J, Linseisen J, Wolfram G. Z Ernahrungswiss; 37(2):190-7 1998 UI: 98363803

13.) [The protective action of ellagic acid in experimental myocarditis] Iakovleva LV, Ivakhnenko AK, Buniatian ND. Eksp Klin Farmakol; 61(3):32-4 1998 UI: 98354527

14.) Effect of cancer chemopreventive agents on microsome-mediated DNA adduction of the breast carcinogen dibenzo[a,l]pyrene. Smith WA, Arif JM, Gupta RC. Mutat Res; 412(3):307-14 1998 UI: 98261326

15.) Modulation of dibenzo[a,l]pyrene-DNA adduction by chemopreventive agents in the human breast epithelial cell line MCF-7 (Meeting abstract). Smith WA, Freeman JW, Gupta RC. Proc Annu Meet Am Assoc Cancer Res; 38:A2422 1997 UI: 98639422

16.) Ellagic acid induces oxidative inactivation of protein kinase C by modifying both catalytic and regulatory domains (Meeting abstract). Chen Z, Gundimeda U, Gopalakrishna R. Proc Annu Meet Am Assoc Cancer Res; 38:A1395 1997 UI: 98638395

17.) Modulation of TCDD-induced fetotoxicity and oxidative stress in embryonic and placental tissues of C57BL/6J mice by vitamin E succinate and ellagic acid. Hassoun EA, Walter AC, Alsharif NZ, Stohs SJ. Toxicology; 124(1):27-37 1997 UI: 98052346

18.) Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity. Hayes MT, Bartley J, Parsons PG, Eaglesham GK, Prakash AS. Biochemistry; 36(35):10646-54 1997 UI: 97419128

19.) Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Soni KB, Lahiri M, Chackradeo P, Bhide SV, Kuttan R. Cancer Lett; 115(2):129-33 1997 UI: 97293062

20.) Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Stoner GD, Morse MA. Cancer Lett; 114(1-2):113-9 1997 UI: 97256427

21.) Experimental evidence for cancer preventive elements in foods. Wargovich MJ. Cancer Lett; 114(1-2):11-7 1997 UI: 97256404

22.) Effects of chemopreventive agents on bioactivation of benzo[a]pyrene (BP) and dibenzo[a,l]pyrene (DBP) as measured via DNA adduction (Meeting abstract). Smith WA, Arif JM, Gupta RC. Proc Annu Meet Am Assoc Cancer Res; 37:1874 1996 UI: 97609998

23.) Organ specific, protocol dependent modulation of 7,12-dimethylbenz[a]anthracene carcinogenesis in rainbow trout (Oncorhynchus mykiss) by dietary ellagic acid. Harttig U, Hendricks JD, Stoner GD, Bailey GS. Carcinogenesis; 17(11):2403-9 1996 UI: 97122435

24.) Chemoprevention of colorectal cancer. Krishnan K, Brenner DE. Gastroenterol Clin North Am; 25(4):821-58 1996 UI: 97120224

25.) Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Eaton EA, Walle UK, Lewis AJ, Hudson T, Wilson AA, Walle T. Drug Metab Dispos; 24(2):232-7 1996 UI: 96351686

26.) Modulation of the mutagenicity and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds. Miller C, Castonguay A, Teel RW. Mutat Res; 368(3-4):221-33 1996 UI: 96305502

27.) Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents. Smith WA, Gupta RC. Carcinogenesis; 17(6):1285-90 1996 UI: 96281687

28.) Structure-function relationships of the dietary anticarcinogen ellagic acid. Barch DH, Rundhaugen LM, Stoner GD, Pillay NS, Rosche WA. Carcinogenesis; 17(2):265-9 1996 UI: 96225897

29.) Anti-genotoxic effects in mice after the interaction between coffee and dietary constituents. Abraham SK. Food Chem Toxicol; 34(1):15-20 1996 UI: 96190851

30.) Anticarcinogenic phase 2 enzyme inducers in edible plants (Meeting abstract). Talalay P, Fahey JW, Prestera T, Wade KL, Zhang Y. Proc Annu Meet Am Assoc Cancer Res; 36:703-4 1995 UI: 96604754

31.) Use of a microsomal activation system as a potential screening method for cancer chemopreventive agents (Meeting abstract). Smith WA, Devanaboyina U, Gupta RC. Proc Annu Meet Am Assoc Cancer Res; 36:A3555 1995 UI: 96602508

32.) Biological activity of diet-derived flavonoids: effects on pS2 expression and cellular proliferation (Meeting abstract). Sathyamoorthy N, Wang TT, Do LD, Phang JM. Proc Annu Meet Am Assoc Cancer Res; 36:A3548 1995 UI: 96600277

33.) Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice. Pereira MA. Anticancer Res; 15(5B):1953-6 1995 UI: 96152424

34.) Pentachlorophenol-induced oxidative DNA damage in mouse liver and protective effect of antioxidants. Sai-Kato K, Umemura T, Takagi A, Hasegawa R, Tanimura A, Kurokawa Y. Food Chem Toxicol; 33(10):877-82 1995 UI: 96077171

35.) Regional chemoprevention of carcinogen-induced tumors in rat colon. Liu T, Mokuolu AO, Rao CV, Reddy BS, Holt PR. Gastroenterology; 109(4):1167-72 1995 UI: 96029317

36.) Polyphenols as cancer chemopreventive agents. Stoner GD, Mukhtar H. J Cell Biochem Suppl; 22:169-80 1995 UI: 96010329

37.) Tumor suppression and anti-initiation by dietary ellagic acid against 7,12-dimethylbenz[a]anthracene (DMBA) in rainbow trout (Meeting abstract). Harttig U, Stoner G, Bailey G. Proc Annu Meet Am Assoc Cancer Res; 36:A739 1995 UI: 95608518

38.) Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Menon LG, Kuttan R, Kuttan G. Cancer Lett; 95(1-2):221-5 1995 UI: 95384993

39.) The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro. Constantinou A, Stoner GD, Mehta R, Rao K, Runyan C, Moon R. Nutr Cancer; 23(2):121-30 1995 UI: 95372233

40.) Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Akagi K, Hirose M, Hoshiya T, Mizoguchi Y, Ito N, Shirai T. Cancer Lett; 94(1):113-21 1995 UI: 95346911

41.) Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Siglin JC, Barch DH, Stoner GD. Carcinogenesis; 16(5):1101-6 1995 UI: 95285520

42.) Ellagic acid induces transcription of the rat glutathione S-transferase-Ya gene. Barch DH, Rundhaugen LM, Pillay NS. Carcinogenesis; 16(3):665-8 1995 UI: 95211955

43.) Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats. Hirose M, Akagi K, Hasegawa R, Yaono M, Satoh T, Hara Y, Wakabayashi K, Ito N. Carcinogenesis; 16(2):217-21 1995 UI: 95163168

44.) Food phytochemicals for cancer prevention I: fruits and vegetables. Huang MT, Osawa T, Ho CT, Rosen RT. ACS Symp Ser; 546:1-427 1994 UI: 96603729

45.) Inhibition of NNK mutagenesis and metabolism by chemopreventive phytochemicals. Miller CH. Diss Abstr Int [B]; 55(6):2119 1994 UI: 95615369

46.) Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Tsuda H, Uehara N, Iwahori Y, Asamoto M, Iigo M, Nagao M, Matsumoto K, Ito M, Hirono I. Jpn J Cancer Res; 85(12):1214-9 1994 UI: 95155154

47.) Ellagic acid induces NAD(P)H:quinone reductase through activation of the antioxidant responsive element of the rat NAD(P)H:quinone reductase gene. Barch DH, Rundhaugen LM. Carcinogenesis; 15(9):2065-8 1994 UI: 95008026

48.) Quantification of induction of rat oesophageal, gastric and pancreatic glutathione and glutathione S-transferases by dietary anticarcinogens. Nijhoff WA, Peters WH. Carcinogenesis; 15(9):1769-72 1994 UI: 95007981

49.) Screening for agents inhibiting the mutagenicity of extracts and constituents of tobacco products. Romert L, Jansson T, Curvall M, Jenssen D. Mutat Res; 322(2):97-110 1994 UI: 94322845

50.) Identification of tricyclic analogs related to ellagic acid as potent/selective tyrosine protein kinase inhibitors. Dow RL, Chou TT, Bechle BM, Goddard C, Larson ER. J Med Chem; 37(14):2224-31 1994 UI: 94309076

51.) Chemoprevention of cancer. Szarka CE, Grana G, Engstrom PF. Curr Probl Cancer; 18(1):6-79 1994 UI: 94273543

52.) Chemopreventive drug development: perspectives and progress. Kelloff GJ, Boone CW, Crowell JA, Steele VE, Lubet R, Sigman CC. Cancer Epidemiol Biomarkers Prev; 3(1):85-98 1994 UI: 94163105

53.) Food and cancer prevention: chemical and biological aspects. Anonymous. Non-serial; Food and Cancer Prevention: Chemical and Biological Aspects. Waldron KW, Johnson IT, Fenwick GR, eds. Cambridge, UK, Royal Society of Chemistry, 461 p., 1993.: 1993 UI: 95616078

54.) Cancer chemoprevention. Anonymous. Non-serial; Cancer Chemoprevention. Wattenberg L, Lipkin M, Boone WB, et al, eds., Boca Raton, FL, CRC Press, 630 p., 1993.: 1993 UI: 95606775

55.) Chemoprevention drug development: perspectives and progress (Meeting abstract). Kelloff GJ, Boone CW, Malone WF, Crowell JA, Steele VE, Perloff M, Sigman CC. Non-serial; Anticarcinogenesis and Radiation Protection, 4th International Conference: Mechanisms, Biomarkers, Molecular Diagnostics and Preventive Strategies. April 18-23, 1993, Baltimore, Maryland, p. 63, 1993.: 1993 UI: 94699779

56.) Chemoprevention drug development at the National Cancer Institute (Meeting abstract). Kelloff GJ, Boone CW, Steele V, Perloff M, Crowell JA. Non-serial; Current Strategies of Cancer Chemoprevention, 13th International Symposium on Cancer. July 6-9, 1993, Sapporo, Japan, p. 11, 1993.: 1993 UI: 94699212

57.) Chemoprevention drug development: preclinical studies and Phase II clinical trials (Meeting abstract). Kelloff GJ, Boone CW, Malone WF, Steele V, Perloff M, Crowell JA. Non-serial; CCPC-93: Second International Cancer Chemo Prevention Conference. April 28-30, 1993, Berlin, Germany, p. 46, 1993.: 1993 UI: 94696733

58.) Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Zhang Z, Hamilton SM, Stewart C, Strother A, Teel RW. Anticancer Res; 13(6A):2341-6 1993 UI: 94127867

59.) Comparative cytotoxicities of selected minor dietary non-nutrients with chemopreventive properties. Babich H, Borenfreund E, Stern A. Cancer Lett; 73(2-3):127-33 1993 UI: 94036760

60.) Lung tumors in strain A mice: application for studies in cancer chemoprevention. Stoner GD, Adam-Rodwell G, Morse MA. J Cell Biochem Suppl; 17F:95-103 1993 UI: 94017849

61.) Protective effects of antioxidants against endrin-induced hepatic lipid peroxidation, DNA damage, and excretion of urinary lipid metabolites. Bagchi D, Hassoun EA, Bagchi M, Stohs SJ. Free Radic Biol Med; 15(2):217-22 1993 UI: 93387736

62.) Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Tanaka T, Kojima T, Kawamori T, Wang A, Suzui M, Okamoto K, Mori H. Carcinogenesis; 14(7):1321-5 1993 UI: 93321268

63.) Ellagic acid embryoprotection in vitro: distribution and effects on DNA adduct formation. Frank AA, Collier JM, Forsyth CS, Zeng W, Stoner GD. Teratology; 47(4):275-80 1993 UI: 93310697

64.) Pulmonary carcinogenesis and its prevention by dietary polyphenolic compounds. Castonguay A. Ann N Y Acad Sci; 686:177-85 1993 UI: 93290257

65.) Cellular and molecular targets for chemoprevention. Anonymous. Non-serial; Cellular and Molecular Targets for Chemoprevention. Steele VE, Stoner GD, Boone CW et al, eds. Boca Raton, FL, CRC, 373 p., 1992.: 1992 UI: 95606652

66.) Synthesis of ellagic acid O-alkyl derivatives and isolation of ellagic acid as a tetrahexanoyl derivative from Fragaria ananassa. Heur YH, Zeng W, Stoner GD, Nemeth GA, Hilton B. J Nat Prod; 55(10):1402-7 1992 UI: 93085361

67.) Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Boukharta M, Jalbert G, Castonguay A. Nutr Cancer; 18(2):181-9 1992 UI: 93065413

68.) Antitumor-promoting activities of tannic acid, ellagic acid, and several gallic acid derivatives in mouse skin. Perchellet JP, Gali HU, Perchellet EM, Klish DS, Armbrust AD. Basic Life Sci; 59:783-801 1992 UI: 93038465

69.) Hydrolyzable tannins: potent inhibitors of hydroperoxide production and tumor promotion in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate in vivo. Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP. Int J Cancer; 51(3):425-32 1992 UI: 92275855

70.) Antitumor-promoting activities of hydrolyzable tannins in mouse skin. Gali HU, Perchellet EM, Klish DS, Johnson JM, Perchellet JP. Carcinogenesis; 13(4):715-8 1992 UI: 92248811

71.) Sequence-selective depurination, DNA interstrand cross-linking and DNA strand break formation associated with alkylated DNA. Prakash AS, Gibson NW. Carcinogenesis; 13(3):425-31 1992 UI: 92191383

72.) CHEMOPREVENTION BY NONNUTRIENT COMPONENTS OF VEGETABLES AND FRUITS. Birt DF, Bresnick E. Hum Nutr: A Compr Treatise; 7:221-60 1991 UI: 92686046

73.) Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Pereira MA, Khoury MD. Cancer Lett; 61(1):27-33 1991 UI: 92110784

74.) The crystal and molecular structure of ellagic acid dihydrate: a dietary anti-cancer agent [published erratum appears in Carcinogenesis 1992 Mar;13(3):513]. Rossi M, Erlebacher J, Zacharias DE, Carrell HL, Iannucci B. Carcinogenesis; 12(12):2227-32 1991 UI: 92083608

75.) QUANTITATION AND LIBERATION OF ELLAGIC ACID IN DIETARY SOURCES, AND ITS EFFECTS, IN COMBINATION WITH 13-CIS RETINOIC ACID, ON THE DEVELOPMENT OF N-NITROSOBENZYLMETHYLAMINE-INDUCED ESOPHAGEAL TUMORS IN F344 RATS. Daniel EM. Diss Abstr Int [B]; 51(10):4787 1991 UI: 91676344

76.) Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Rao CV, Tokumo K, Rigotty J, Zang E, Kelloff G, Reddy BS. Cancer Res; 51(17):4528-34 1991 UI: 91339132

77.) Inhibitory effect of ellagic acid on genotoxicity induced by aflatoxins B1 and G1. Gorski T, Gorska E, Odlanicki J, Sikora M. IARC Sci Publ; (105):550-1 1991 UI: 91310203

78.) Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Castonguay A, Pepin P, Stoner GD. Exp Lung Res; 17(2):485-99 1991 UI: 91266816

79.) Inhibition of tumor promoter-induced ornithine decarboxylase activity by tannic acid and other polyphenols in mouse epidermis in vivo. Gali HU, Perchellet EM, Perchellet JP. Cancer Res; 51(11):2820-5 1991 UI: 91235179

80.) The effects of ellagic acid and 13-cis-retinoic acid on N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats. Daniel EM, Stoner GD. Cancer Lett; 56(2):117-24 1991 UI: 91152701

81.) Combination of blocking agents and suppressing agents in cancer prevention. Ip C, Ganther HE. Carcinogenesis; 12(2):365-7 1991 UI: 91138220

82.) FOOD MUTAGENS: FACTORS THAT MODULATE THEIR METABOLIC ACTIVATION. Ayrton AD. Diss Abstr Int [B]; 50(12):5398 1990 UI: 90666780

83.) The effect of retinoids, carotenoids and phenolics on chromosomal instability of bovine papillomavirus DNA-carrying cells. Stich HF, Tsang SS, Palcic B. Mutat Res; 241(4):387-93 1990 UI: 90331956

84.) Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Steele VE, Kelloff GJ, Wilkinson BP, Arnold JT. Cancer Res; 50(7):2068-74 1990 UI: 90199728

85.) Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Mandal S, Stoner GD. Carcinogenesis; 11(1):55-61 1990 UI: 90106890

86.) Ellagic acid effects on the carcinogenicity, DNA-binding and metabolism of 7,12-dimethylbenz(a)anthracene (DMBA). Singletary K, Liao CH. In Vivo; 3(3):173-5 1989 UI: 92135639

87.) ELLAGIC ACID EFFECTS ON THE CARCINOGENICITY, DNA-BINDING AND METABOLISM OF 7,12-DIMETHYLBENZ(A)ANTHRACENE (DMBA). Singletary K, Liao C. In Vivo; 3(3):173-5 1989 UI: 91668959

88.) Chemical strategies for the inactivation of bay-region diol epoxides, ultimate carcinogens derived from polycyclic aromatic hydrocarbons. Sayer JM, Whalen DL, Jerina DM. Drug Metab Rev; 20(2-4):155-82 1989 UI: 90032259

89.) INHIBITION OF N-NITROSAMINE CARCINOGENESIS AND AFLATOXIN DNA DAMAGE BY ELLAGIC ACID. Mandal-Chaudhuri S. Diss Abstr Int [B]; 49(7):2577 1989 UI: 89655083

90.) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster respiratory tissues cultured with ellagic acid [published erratum appears in Cancer Lett 1989 Sep 15;47(1-2):161]. Castonguay A, Allaire L, Charest M, Rossignol G, Boutet M. Cancer Lett; 46(2):93-105 1989 UI: 89323981

91.) Comparative studies of the inhibitory properties of antibiotics on human immunodeficiency virus and avian myeloblastosis virus reverse transcriptases and cellular DNA polymerases. Take Y, Inouye Y, Nakamura S, Allaudeen HS, Kubo A. J Antibiot (Tokyo); 42(1):107-15 1989 UI: 89155329

92.) Dietary ellagic acid reduces the esophageal microsomal metabolism of methylbenzylnitrosamine. Barch DH, Fox CC. Cancer Lett; 44(1):39-44 1989 UI: 89135843

93.) Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. Tanaka T, Iwata H, Niwa K, Mori Y, Mori H. Jpn J Cancer Res; 79(12):1297-303 1988 UI: 89174199

94.) Ellagic acid derivatives of Agrostistachys hookeri. Choi YH, Pezzuto JM, Kinghorn AD, Farnsworth NR. Planta Med; 54(6):511-3 1988 UI: 89099412

95.) Dietary inhibitors of mutagenesis and carcinogenesis. Hayatsu H, Arimoto S, Negishi T. Mutat Res; 202(2):429-46 1988 UI: 89057035

96.) Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4. Dumenco LL, Everson B, Culp LA, Ratnoff OD. J Lab Clin Med; 112(3):394-400 1988 UI: 88316031

97.) Inhibition of N-nitrosobenzylmethylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid. Mandal S, Shivapurkar NM, Galati AJ, Stoner GD. Carcinogenesis; 9(7):1313-6 1988 UI: 88253661

98.) Inhibition of aflatoxin B1 mutagenesis in Salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid. Mandal S, Ahuja A, Shivapurkar NM, Cheng SJ, Groopman JD, Stoner GD. Carcinogenesis; 8(11):1651-6 1987 UI: 88027529

99.) Ellagic acid toxicity and interaction with benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in human bronchial epithelial cells. Teel RW, Babcock MS, Dixit R, Stoner GD. Cell Biol Toxicol; 2(1):53-62 1986 UI: 90002322

100.) AMERICAN SOCIETY OF PREVENTIVE ONCOLOGY. MARCH 5-7, 1986, BETHESDA, MD. Anonymous. Non-serial; American Society of Preventive Oncology. March 5-7, 1986, Bethesda, MD, 1986.: 1986 UI: 87630260

101.) Effect of ellagic acid and 3-O-decylellagic acid on the formation of benzo[a]pyrene-derived DNA adducts in vivo and on the tumorigenicity of 3-methylcholanthrene in mice. Smart RC, Huang MT, Chang RL, Sayer JM, Jerina DM, Wood AW, Conney AH. Carcinogenesis; 7(10):1669-75 1986 UI: 87002893

102.) Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3'-di-O-methylellagic acid in mice. Smart RC, Huang MT, Chang RL, Sayer JM, Jerina DM, Conney AH. Carcinogenesis; 7(10):1663-7 1986 UI: 87002892

103.) Pharmacological modification of epidermal detoxification systems. Bickers DR, Das M, Mukhtar H. Br J Dermatol; 115 Suppl 31:9-16 1986 UI: 86296561

104.) Inhibition of 3-methylcholanthrene-induced skin tumorigenicity in BALB/c mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Mukhtar H, Das M, Bickers DR. Cancer Res; 46(5):2262-5 1986 UI: 86189522

105.) Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. Teel RW. Cancer Lett; 30(3):329-36 1986 UI: 86189483

106.) Evaluation of anti-inflammatory agents using a model of granuloma formation evoked by divinyl copolymer beads in the mouse lung. Coleman SE, Hood CI, Schoen FJ, Rheinhardt JM. J Biomed Mater Res; 20(3):301-14 1986 UI: 86168363

107.) Combined effects of butylated hydroxyanisole and other antioxidants in induction of forestomach lesions in rats. Hirose M, Hagiwara A, Masui T, Inoue K, Ito N. Cancer Lett; 30(2):169-74 1986 UI: 86161442

108.) Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action. Das M, Bickers DR, Mukhtar H. Carcinogenesis; 6(10):1409-13 1985 UI: 86002623

109.) Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse. Chang RL, Huang MT, Wood AW, Wong CQ, Newmark HL, Yagi H, Sayer JM, Jerina DM, Conney AH. Carcinogenesis; 6(8):1127-33 1985 UI: 85255346

110.) Inhibition of benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid. Dixit R, Teel RW, Daniel FB, Stoner GD. Cancer Res; 45(7):2951-6 1985 UI: 85227981

111.) Spontaneous fibrinolysis in whole human plasma. Identification of tissue activator-related protein as the major plasminogen activator causing spontaneous activity in vitro. Wun TC, Capuano A. J Biol Chem; 260(8):5061-6 1985 UI: 85182630

112.) Effect of ellagic and caffeic acids on covalent binding of benzo[a]pyrene to epidermal DNA of mouse skin in organ culture. Shugart L, Kao J. Int J Biochem; 16(5):571-3 1984 UI: 84209314

113.) Protection against 3-methylcholanthrene-induced skin tumorigenesis in Balb/C mice by ellagic acid. Mukhtar H, Das M, Del Tito BJ Jr, Bickers DR. Biochem Biophys Res Commun; 119(2):751-7 1984 UI: 84178448

114.) Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Lesca P. Carcinogenesis; 4(12):1651-3 1983 UI: 84082484

115.) Inhibition of epidermal metabolism and DNA-binding of benzo[a]pyrene by ellagic acid. Del Tito BJ Jr, Mukhtar H, Bickers DR. Biochem Biophys Res Commun; 114(1):388-94 1983 UI: 83282781

116.) Inability of several mutagen-blocking agents to inhibit 1,2-dimethylhydrazine-induced DNA-damaging activity in colonic epithelium. Wargovich MJ, Newmark HL. Mutat Res; 121(1):77-80 1983 UI: 83244824

117.) INHIBITION OF THE MUTAGENICITY OF BAY-REGION DIOL EPOXIDES OF POLYCYCLIC AROMATIC HYDROCARBONS BY NATURALLY OCCURRING PLANT PHENOLS: EXCEPTIONAL ACTIVITY OF ELLAGIC ACID. Wood AW, Huang MT, Chang RL, Newmark HL, Lehr RE, Yagi H, Sayer JM, Jerina DM, Conney AH. Proc Natl Acad Sci U S A; 79(18):5513-5517 1982 UI: 82631054

118.) Naturally occurring food toxicants: phenolic substances of plant origin common in foods. Singleton VL. Adv Food Res; 27:149-242 1981 UI: 82088187

119.) PLASMA PREKALLIKREIN (FLETCHER FACTOR) DEFICIENCY IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Waddell CC, Brown JA, Udden MM. South Med J; 73(12):1653-1655 1980 UI: 81695551

120.) [INFLUENCE OF ELLAGIC ACID AND HEPARIN ON COAGULATION, FIBRINOLYSIS AND METASTASIS IN TRAUMATIZED ANIMALS]. Agostino D, Agostino N. Sangre (Barc); 25(6):989-998 1980 UI: 81613131

121.) [Influence of ellagic acid and heparin on coagulation, fibrinolysis and metastasis in traumatized animals (author's transl)] Agostino D, Agostino N. Sangre (Barc); 25(6):989-98 1980 UI: 81177563

122.) Enhancement of pulmonary metastases following the intravenous infusion of a suspension of ellagic acid in traumatized rats. Agostino D, Agostino N. Tumori; 66(3):285-93 1980 UI: 81080289

123.) Plasma prekallikrein (Fletcher factor) deficiency in a patient with chronic lymphocytic leukemia. Waddell CC, Brown JA, Udden MM. South Med J; 73(12):1653-5 1980 UI: 81078975

124.) ENHANCEMENT OF PULMONARY METASTASES FOLLOWING THE INTRAVENOUS INFUSION OF A SUSPENSION OF ELLAGIC ACID IN TRAUMATIZED RATS. Agostino D, Agostino N. Tumori; 66(3):285-293 1980 UI: 80676502

125.) EFFECT OF TANNIC ACID AND ELLAGIC ACID ON THE INFECTIVITY OF POTATO VIRUS X IN TISSUE CULTURE. Verma VS, Raychaudhuri SP. Naturwissenschaften; 55(11):546 1968 UI: 69700990

126.) ANTITUMOR ACTIVITY OF JUGLANS NIGRA (BLACK WALNUT) EXTRACTIVES. Bhargava UC, Westfall BA. J Pharm Sci; 57(10):1674-1677 1968 UI: 68801494

127.) [EFFECT OF ELLAGIC ACID ON THE INDUCTION AND DEVELOPMENT OF SOLID I.R.E. RETICULUM CELL SARCOMA] Fumarola D, Maruccio L, Restuccia P. Haematologica; 52(9):701-706 1967 UI: 69701760

Home

Webmaster: ©2003 Jeff Tollefson - Genetrix Systems™
Sun City, California USA +1 (909) 679-3519
TheraPure.com International™ is a trademark and subsidiary of Genetrix Systems™

Red Raspberry Ellagic Acid

Home